Precision Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Precision BioSciences
DTIL Stock  USD 7.26  0.76  11.69%   
Precision BioSciences financial statements provide useful quarterly and yearly information to potential Precision BioSciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Precision BioSciences financial statements helps investors assess Precision BioSciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Precision BioSciences' valuation are summarized below:
Gross Profit
25.1 M
Profit Margin
0.1148
Market Capitalization
55.7 M
Enterprise Value Revenue
0.1802
Revenue
75.1 M
There are over one hundred nineteen available trending fundamental ratios for Precision BioSciences, which can be analyzed over time and compared to other ratios. We recommend to check out Precision BioSciences' recent fundamental drivers against the all of the trends between 2010 and 2024. The value of Market Cap is estimated to slide to about 40 M. Enterprise Value is expected to rise to about (41.2 M) this year

Precision BioSciences Total Revenue

35.79 Million

Check Precision BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Precision BioSciences' main balance sheet or income statement drivers, such as Interest Income of 8.2 M, Interest Expense of 2.3 M or Selling General Administrative of 29 M, as well as many indicators such as Price To Sales Ratio of 0.82, Dividend Yield of 0.0 or PTB Ratio of 2.34. Precision financial statements analysis is a perfect complement when working with Precision BioSciences Valuation or Volatility modules.
  
Check out the analysis of Precision BioSciences Correlation against competitors.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.

Precision BioSciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets179.4 M159.8 M138.3 M
Slightly volatile
Other Current Liabilities6.7 M11.4 M6.4 M
Pretty Stable
Total Current Liabilities34 M50 M22.1 M
Slightly volatile
Other Liabilities64.4 M83.8 M85.4 M
Slightly volatile
Accounts Payable1.8 M3 M1.5 M
Slightly volatile
Cash134.8 M116.7 M111.7 M
Slightly volatile
Other Assets0.951.02.1 M
Slightly volatile
Cash And Short Term Investments134.8 M116.7 M111.7 M
Slightly volatile
Net Receivables13.4 M12.8 M2.8 M
Slightly volatile
Common Stock Shares Outstanding3.1 M3.8 M8.6 M
Slightly volatile
Capital Surpluse591.3 M563.2 M195.6 M
Slightly volatile
Total Liabilities129.6 M140.9 M112.7 M
Slightly volatile
Total Current Assets147.2 M136.4 M119 M
Slightly volatile
Intangible Assets380 K400 K700.3 K
Slightly volatile
Property Plant Equipment25 M23.2 M15.2 M
Slightly volatile
Property Plant And Equipment Net27.9 M14.6 M17.5 M
Slightly volatile
Current Deferred Revenue22.1 M12 M13.6 M
Slightly volatile
Non Current Assets Total36.1 M23.4 M21.6 M
Slightly volatile
Non Currrent Assets Other213.7 K225 K1.2 M
Slightly volatile
Liabilities And Stockholders Equity189.5 M159.8 M127 M
Slightly volatile
Non Current Liabilities Total94.4 M90.9 M88.3 M
Very volatile
Other Current Assets8.5 M6.9 M4.9 M
Slightly volatile
Other Stockholder Equity345.3 M508.5 M177 M
Slightly volatile
Property Plant And Equipment Gross40.5 M40.1 M23.7 M
Slightly volatile
Net Working Capital115.9 M86.4 M82.6 M
Slightly volatile
Short Term Debt24.7 M23.5 M5.3 M
Slightly volatile
Inventory11.1 M8.7 M9.7 M
Pretty Stable
Short and Long Term Debt Total21.4 M31.3 M13.6 M
Slightly volatile
Capital Lease Obligations6.2 M8.9 M9.5 M
Slightly volatile
Non Current Liabilities Other65.3 M110.2 M23.8 M
Slightly volatile
Long Term Debt13.6 M25.6 M6.1 M
Slightly volatile
Long Term Debt Total13.6 M25.6 M6.1 M
Slightly volatile
Common Stock800900980
Slightly volatile
Short and Long Term Debt17.9 M20.2 M22 M
Slightly volatile

Precision BioSciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income8.2 M7.8 M2.1 M
Slightly volatile
Selling General Administrative29 M39.1 M18.5 M
Slightly volatile
Total Revenue35.8 M48.7 M22.5 M
Slightly volatile
Gross Profit33.4 M40.5 M21.2 M
Slightly volatile
Research Development69.3 M49.4 M41.9 M
Slightly volatile
Total Operating Expenses98.9 M92.5 M60.9 M
Slightly volatile
Net Interest Income5.9 M5.7 M1.9 M
Slightly volatile
Other Operating Expenses110.6 M92.5 M67.5 M
Slightly volatile
Reconciled Depreciation7.4 M9 M4.3 M
Slightly volatile
Selling And Marketing Expenses3.4 M3.8 M4.1 M
Slightly volatile

Precision BioSciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation6.5 M8.3 M3.8 M
Slightly volatile
Dividends Paid9.9 M11.2 M12.2 M
Slightly volatile
Capital Expenditures2.2 M2.3 M5.3 M
Pretty Stable
End Period Cash Flow134.8 M116.7 M111.7 M
Slightly volatile
Stock Based Compensation11.8 M14 M6 M
Slightly volatile
Begin Period Cash Flow135.7 M189.6 M110.2 M
Slightly volatile
Issuance Of Capital Stock2.1 M2.2 M86.5 M
Slightly volatile
Cash Flows Other Operating16.3 M28.8 M12.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.820.863358.3 K
Slightly volatile
Days Sales Outstanding10195.866235.6029
Slightly volatile
Stock Based Compensation To Revenue0.280.28810.2125
Slightly volatile
Capex To Depreciation0.260.2762.6573
Slightly volatile
Inventory Turnover0.951.071.168
Slightly volatile
Days Of Inventory On Hand245276300
Slightly volatile
Payables Turnover2.642.781312.3116
Slightly volatile
Sales General And Administrative To Revenue1.250.80221.1931
Pretty Stable
Research And Ddevelopement To Revenue0.961.01282.0281
Pretty Stable
Capex To Revenue0.04440.04680.3973
Very volatile
Cash Per Share46.8630.373534.3912
Slightly volatile
Days Payables Outstanding13813140.8763
Slightly volatile
Intangibles To Total Assets0.00240.00250.0037
Slightly volatile
Net Debt To EBITDA4.352.66566.9611
Slightly volatile
Current Ratio2.592.72797.8166
Slightly volatile
Receivables Turnover3.623.807449.8166
Pretty Stable
Graham Number39.8941.99375.2333
Slightly volatile
Debt To Equity1.251.18830.2221
Slightly volatile
Capex Per Share0.560.5932.6889
Pretty Stable
Revenue Per Share12.2612.68468.9947
Slightly volatile
Interest Debt Per Share6.746.41481.7199
Slightly volatile
Debt To Assets0.150.14030.0364
Slightly volatile
Operating Cycle91.0795.8662287
Slightly volatile
Days Of Payables Outstanding13813140.8763
Slightly volatile
Ebt Per Ebit0.780.97240.9444
Very volatile
Long Term Debt To Capitalization0.250.240.0718
Slightly volatile
Total Debt To Capitalization0.570.5430.1257
Slightly volatile
Debt Equity Ratio1.251.18830.2221
Slightly volatile
Quick Ratio2.592.72797.7434
Slightly volatile
Net Income Per E B T0.871.44191.008
Pretty Stable
Cash Ratio2.222.33427.5404
Slightly volatile
Days Of Inventory Outstanding245276300
Slightly volatile
Days Of Sales Outstanding10195.866235.6029
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.311.02711.115
Slightly volatile
Fixed Asset Turnover3.53.33721.8782
Pretty Stable
Debt Ratio0.150.14030.0364
Slightly volatile
Price Sales Ratio0.820.863358.3 K
Slightly volatile
Asset Turnover0.320.3050.1466
Slightly volatile
Gross Profit Margin0.590.83060.6505
Pretty Stable

Precision BioSciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap40 M42.1 M408.8 B
Slightly volatile

Precision Fundamental Market Drivers

Forward Price Earnings2.1106
Cash And Short Term Investments116.7 M

Precision Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Precision BioSciences Financial Statements

Precision BioSciences investors utilize fundamental indicators, such as revenue or net income, to predict how Precision Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue12 M22.1 M
Total Revenue48.7 M35.8 M
Cost Of Revenue8.3 M8.7 M
Stock Based Compensation To Revenue 0.29  0.28 
Sales General And Administrative To Revenue 0.80  1.25 
Research And Ddevelopement To Revenue 1.01  0.96 
Capex To Revenue 0.05  0.04 
Revenue Per Share 12.68  12.26 
Ebit Per Revenue(0.90)(0.94)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports:
How To Invest In Precision
Details
Is Precision Stock a good investment?
Details
What is Precision BioSciences' Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Precision BioSciences Correlation against competitors.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.4
Revenue Per Share
12.872
Quarterly Revenue Growth
(0.96)
Return On Assets
(0.06)
Return On Equity
0.2444
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY